Hematology/Oncology Secrets
- 3rd Edition - May 28, 2003
- Imprint: Hanley & Belfus
- Author: Marie E. Wood
- Language: English
This highly popular book in the proven question-and-answer format of the Secrets Series® is better than ever in this completely updated new edition. The major sections are General… Read more
Purchase options
This highly popular book in the proven question-and-answer format of the Secrets Series® is better than ever in this completely updated new edition. The major sections are General Concepts, General Hematology, Malignant Hematology, Care of the Cancer Patient, and Solid Tumors. Concise, and yet comprehensive with over 90 chapters written by experts in the field, this book presents all the need-to-know key information and provides the insights, pearls, and "secrets" that are the hallmark of the series.
- Comprehensive, yet concise coverage of the full range of hematology/oncology
- In approximately 100 chapters, major authorities in the field offer their practical tips, pearls, and "secrets"
- Bulleted lists, tables, and illustrations for quick review
Students and Residents; Hematologists, Oncologists, Oncology Nurses
I GENERAL CONCEPTS
1. Evaluation and Management of the Palpable Breast Mass
2. Evaluation of a Lung Mass
3. Evaluation of a Testicular Mass
4. Intracranial Masses
5. Evaluation of Anemia
6. Evaluation of the Patient with a Bleeding Diathesis
7. Evaluation of Adenopathy
8. Evaluation of Leukocytosis
II GENERAL HEMATOLOGY
9. Iron Deficiency Anemia
10. Megaloblastic Anemia
11. Hemolytic Anemias
12. Aplastic Anemia
13. Sickle Cell Disease and Thalassemias
14. Polycynthemic States
15. Iron Overload
16. Disseminated Intravascular Coagulation
17. Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome
18. Idiopathic Thrombocytopenic Purpura
19. Thrombocytosis
20. Hemophilia
21. Acquired Factor Deficiencies
22. The Hypercoagulable State
23. Neutropenia
24. Myelodysplastic Syndromes
III MALIGNANT HEMATOLOGY
25. Acute Leukemia: Classification and Laboratory Evaluation
26. Acute Myelogenous and Lymphocytic Leukemias
27. Chronic Lymphocytic Leukemia
28. Chronic Myelogenous Leukemia
29. Hairy Cell Leukemia
30. Non-Hodgkin’s Lymphoma: Classification and Pathology
31. Low-grade Non-Hodgkin’s Lymphoma
32. Aggressive and Highly Aggressive Non-Hodgkin’s Lymphoma
33. Cutaneous Lymphomas
34. Multiple Myeloma
35. Hodgkin’s Disease
IV GENERAL CARE OF THE CANCER PATIENT
36. Carcinogenesis
37. Cancer in the Elderly
38. Cancer Prevention
39. Cancer Chemotherapy: Prevention and Management of Common Toxicities
40. Cancer Pain Management
41. Infectious Complications of Chemotherapy
42. Gastrointestinal Complications of Chemotherapy
43. Hematologic Complications of Chemotherapy
44. Colony Stimulating Factors
45. Biologic Therapy of Cancer
46. Hematopoietic Stem Cell Transplantation
47. Principles of Radiation Oncology
48. Radiation Oncology: Therapeutics
49. Hypercalcemia of Malignancy
50. Paraneoplastic Neurologic Syndromes
51. Endocrine Paraneoplastic Syndromes
52. Skeletal Complications of Malignancy
53. Superior Vena Cava Syndrome
54. Neutropenic Fever
55. Leukostasis
56. Psychosocial Aspects of Cancer Care
57. Fatigue in the Cancer Patient
58. Palliative Care and End-of-Life Decision Making
59. Hospice Care
V SOLID TUMORS
60. Head and Neck Cancer
61. Breast Cancer
62. Lung Cancer
63. Esophageal Cancer
64. Gastric Cancer
65. Colorectal Cancer
66. Tumors of the Liver and Biliary Tree
67. Pancreatic Cancer
68. Ovarian Cancer
69. Carcinoma of the Uterine Cervix and Endometrium
70. Testicular Cancer
71. Renal and Bladder Cancer
72. Prostate Cancer
73. Cutaneous Melanoma
74. Nonmelanoma Skin Cancer
75. Primary Brain Tumors
76. Thyroid and Parathyroid Cancer
77. Carcinoid Syndrome and Pancreatic Islet Cell Tumors
78. Osteogenic Sarcoma
79. Soft Tissue Sarcomas
80. Cancer of Unknown Primary Site
VI PEDIATRIC ONCOLOGY
81. Wilms Tumor
82. Childhood Acute Lymphoblastic Leukemia
83. Osteogenic Sarcoma and Ewing’s Sarcoma in Children
84. Childhood Brain Tumors
VII HIV-RELATED DISEASES
85. AIDS-Associated Lymphomas
86. Kaposi’s Sarcoma
87. Hematologic Abnormalities in HIV Infection
VII CANER GENETICS
88. The Use of Molecular Diagnostics in Malignancy
89. Counseling for Cancer Genetics
90. High-risk Cancer Screening and Prevention
91. Breast Cancer Genetics
92. Colon Cancer Genetics
93. Hereditary Malignancies
94. Targeted Therapy
1. Evaluation and Management of the Palpable Breast Mass
2. Evaluation of a Lung Mass
3. Evaluation of a Testicular Mass
4. Intracranial Masses
5. Evaluation of Anemia
6. Evaluation of the Patient with a Bleeding Diathesis
7. Evaluation of Adenopathy
8. Evaluation of Leukocytosis
II GENERAL HEMATOLOGY
9. Iron Deficiency Anemia
10. Megaloblastic Anemia
11. Hemolytic Anemias
12. Aplastic Anemia
13. Sickle Cell Disease and Thalassemias
14. Polycynthemic States
15. Iron Overload
16. Disseminated Intravascular Coagulation
17. Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome
18. Idiopathic Thrombocytopenic Purpura
19. Thrombocytosis
20. Hemophilia
21. Acquired Factor Deficiencies
22. The Hypercoagulable State
23. Neutropenia
24. Myelodysplastic Syndromes
III MALIGNANT HEMATOLOGY
25. Acute Leukemia: Classification and Laboratory Evaluation
26. Acute Myelogenous and Lymphocytic Leukemias
27. Chronic Lymphocytic Leukemia
28. Chronic Myelogenous Leukemia
29. Hairy Cell Leukemia
30. Non-Hodgkin’s Lymphoma: Classification and Pathology
31. Low-grade Non-Hodgkin’s Lymphoma
32. Aggressive and Highly Aggressive Non-Hodgkin’s Lymphoma
33. Cutaneous Lymphomas
34. Multiple Myeloma
35. Hodgkin’s Disease
IV GENERAL CARE OF THE CANCER PATIENT
36. Carcinogenesis
37. Cancer in the Elderly
38. Cancer Prevention
39. Cancer Chemotherapy: Prevention and Management of Common Toxicities
40. Cancer Pain Management
41. Infectious Complications of Chemotherapy
42. Gastrointestinal Complications of Chemotherapy
43. Hematologic Complications of Chemotherapy
44. Colony Stimulating Factors
45. Biologic Therapy of Cancer
46. Hematopoietic Stem Cell Transplantation
47. Principles of Radiation Oncology
48. Radiation Oncology: Therapeutics
49. Hypercalcemia of Malignancy
50. Paraneoplastic Neurologic Syndromes
51. Endocrine Paraneoplastic Syndromes
52. Skeletal Complications of Malignancy
53. Superior Vena Cava Syndrome
54. Neutropenic Fever
55. Leukostasis
56. Psychosocial Aspects of Cancer Care
57. Fatigue in the Cancer Patient
58. Palliative Care and End-of-Life Decision Making
59. Hospice Care
V SOLID TUMORS
60. Head and Neck Cancer
61. Breast Cancer
62. Lung Cancer
63. Esophageal Cancer
64. Gastric Cancer
65. Colorectal Cancer
66. Tumors of the Liver and Biliary Tree
67. Pancreatic Cancer
68. Ovarian Cancer
69. Carcinoma of the Uterine Cervix and Endometrium
70. Testicular Cancer
71. Renal and Bladder Cancer
72. Prostate Cancer
73. Cutaneous Melanoma
74. Nonmelanoma Skin Cancer
75. Primary Brain Tumors
76. Thyroid and Parathyroid Cancer
77. Carcinoid Syndrome and Pancreatic Islet Cell Tumors
78. Osteogenic Sarcoma
79. Soft Tissue Sarcomas
80. Cancer of Unknown Primary Site
VI PEDIATRIC ONCOLOGY
81. Wilms Tumor
82. Childhood Acute Lymphoblastic Leukemia
83. Osteogenic Sarcoma and Ewing’s Sarcoma in Children
84. Childhood Brain Tumors
VII HIV-RELATED DISEASES
85. AIDS-Associated Lymphomas
86. Kaposi’s Sarcoma
87. Hematologic Abnormalities in HIV Infection
VII CANER GENETICS
88. The Use of Molecular Diagnostics in Malignancy
89. Counseling for Cancer Genetics
90. High-risk Cancer Screening and Prevention
91. Breast Cancer Genetics
92. Colon Cancer Genetics
93. Hereditary Malignancies
94. Targeted Therapy
- Edition: 3
- Published: May 28, 2003
- Imprint: Hanley & Belfus
- Language: English
MW
Marie E. Wood
Affiliations and expertise
Professor of Medicine, Hematology/Oncology Unit, Director, Familial Cancer Program, University of Vermont School of Medicine, Fletcher Allen Health Care, Burlington, VT